Physicians practicing sclerotherapy should be aware of the possible local and systemic AE of sclerotherapy, inform patients accordingly and be prepared for the appropriate management of the rare but possibly lethal serious AE.
No takes yet. Share an insight, caveat, or question.
Eugenia Yiannakopoulou (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: